Reis Pereira Pedro, Almeida Manuela, Ribeiro Bárbara, Oliveira João, Costa Luisa, Pedroso Sofia, Martins La Salete, Dias Leonídio, Malheiro Jorge
Nephrology, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, PRT.
Nephrology, Dialysis, and Transplantation, Unit for Multidisciplinary Research in Biomedicine - Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Porto, PRT.
Cureus. 2022 Oct 11;14(10):e30189. doi: 10.7759/cureus.30189. eCollection 2022 Oct.
Kidney transplantation (KT) from living donors has been shown to have multiple benefits compared to those from deceased donors. We sought to compare significant graft outcomes, namely acute rejection (AR), graft function, and survival between transplant recipients who received a kidney from living related donor (LRD) and living unrelated donor (LURD).
Our cohort comprised 198 donor and recipient pairs undergoing living-donor KT at our center over 10 years. The LRD recipients were compared with LURD recipients according to demographic and clinical characteristics, transplant variables (including immunosuppression), graft function, survival, and AR rate.
The estimated glomerular filtration rate (eGFR) was similar in both groups over the follow-up time i.e., 60-65 mL/min (p>0.05 over 10 years). Censored graft survival was similar between LRD and LURD recipients (96.9% vs. 98.0% at five years and 87.8% vs. 79.4% at 10 years, respectively; p=0.837). The LURD recipients had a higher incidence of AR, although LURD recipient status was not an independent risk factor for AR. Multivariate analysis showed that human leukocyte antigen (HLA)-DR mismatch (MM) was an independent predictor of AR (hazard ratio (HR) 2.256, p<0.05). Both HLA-A and HLA-B MM did not affect the AR HR between the groups.
Graft function and censored graft survival rates were similar between LURD and LRD KT recipients in our study. The AR was higher in LURD recipients, although the LURD recipient status was not an independent risk factor for AR. The HLA-DR MM was an independent predictor of AR, while HLA-A and HLA-B MM did not affect AR HR between groups of patients.
与 deceased donors 相比,活体供肾肾移植(KT)已显示出多种益处。我们试图比较接受活体亲属供肾(LRD)和活体非亲属供肾(LURD)的移植受者之间的显著移植结局,即急性排斥反应(AR)、移植肾功能和生存率。
我们的队列包括在我们中心 10 年间接受活体供肾 KT 的 198 对供受者。根据人口统计学和临床特征、移植变量(包括免疫抑制)、移植肾功能、生存率和 AR 发生率,将 LRD 受者与 LURD 受者进行比较。
在随访期间,两组的估计肾小球滤过率(eGFR)相似,即 60 - 65 mL/min(10 年间 p>0.05)。LRD 和 LURD 受者的截尾移植生存率相似(5 年时分别为 96.9%对 98.0%,10 年时分别为 87.8%对 79.4%;p = 0.837)。LURD 受者的 AR 发生率较高,尽管 LURD 受者状态不是 AR 的独立危险因素。多变量分析显示,人类白细胞抗原(HLA)-DR 错配(MM)是 AR 的独立预测因素(风险比(HR)2.256,p<0.05)。HLA - A 和 HLA - B MM 均不影响两组之间的 AR HR。
在我们的研究中,LURD 和 LRD KT 受者的移植肾功能和截尾移植生存率相似。LURD 受者的 AR 较高,尽管 LURD 受者状态不是 AR 的独立危险因素。HLA - DR MM 是 AR 的独立预测因素,而 HLA - A 和 HLA - B MM 不影响患者组之间的 AR HR。